Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **superior laryngeal nerve** is a branch of the vagus nerve (cranial nerve X), arising from its inferior ganglion and splitting into two main branches: the internal laryngeal nerve (which provides sensory innervation to the mucosa of the larynx above the vocal folds, epiglottis, and base of tongue) and the external laryngeal nerve (which supplies motor innervation to the cricothyroid muscle, affecting vocal cord tension and pitch). The superior laryngeal nerve does not represent a molecular druggable target like a receptor, transporter, or enzyme; instead, it is a mixed nerve vital for voice production and airway protection, but primarily a surgical and anatomical structure, not a molecular pharmacological target[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superior laryngeal nerve (SLN).